Compare PRAA & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PRAA | BME |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 536.7M |
| IPO Year | N/A | N/A |
| Metric | PRAA | BME |
|---|---|---|
| Price | $17.14 | $40.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 387.6K | 34.0K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $1,161,679,000.00 | N/A |
| Revenue This Year | $7.85 | N/A |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $12.29 | $35.53 |
| 52 Week High | $23.97 | $43.20 |
| Indicator | PRAA | BME |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 54.98 |
| Support Level | $16.48 | $39.81 |
| Resistance Level | $18.37 | $40.67 |
| Average True Range (ATR) | 0.69 | 0.41 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 53.93 | 38.74 |
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.